The opinions expressed herein are the guest's alone and have not been reviewed by a WebMD physician. If you have questions about your health, you should consult your personal physician. This event is ...

But now, 13 years after the FDA initially blessed it for skin cancer, the U.S. regulator has approved Keytruda as a second- ...

(CBS/AP) Avastin for breast cancer is out. The FDA says the drug should no longer be used for breast cancer because there's no proof it extends patients' lives - and it causes dangerous side effects.

Medicare to continue to cover Avastin for breast cancer treatment, despite FDA. June 30, 2011 — -- Medicare will continue to cover Avastin for breast cancer treatment even if U.S. Food and Drug ...

This recent readout follows successful data from another combination including Braftovi in mCRC.

Intensifying the chemotherapy component of a standard regimen containing Avastin reduced the risk of death and increased five-year overall survival in newly diagnosed metastatic colorectal cancer.

SILVER SPRING, Md. - A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients, clearing the way ...

First, some background. In 2004, the FDA approved Avastin for first-line treatment of patients with metastatic, or malignant, colorectal cancer. The tremendous success of Avastin turned Genentech from ...

In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the ...

Update 4:06 p.m.: A panel advising the Food and Drug Administration voted against an appeal by Genentech to preserve the approval of Avastin as a treatment for advanced breast cancer. In unanimous ...

A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients, clearing the way for the U.S.

Fake version does not contain the cancer-fighting ingredient, FDA warns. Feb. 15, 2012— -- Cancer patients are furious that a counterfeit version of the drug Avastin has landed in U.S. clinics.